The New England Journal of Medicine
TAKE-HOME MESSAGE
This retrospective study evaluated
the effectiveness of the Pfizer (BNT162b2) COVID-19 vaccine in preventing
reinfection in patients who had recovered from COVID-19.
A total of 149,039 patients who had
recovered from COVID-19 were included, and, of these, 56% were subsequently...